Skip to content

Conventional Flap Versus Vestibular Flap in Bone Augmentation

Assessment of Vestibular Shifted Flap Versus Conventional Flap on Ridge Augmentation in Patients With Anterior Maxillary Bony Deficiency: a Randomized Control Trial

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07664098
Acronym
(RCT)
Enrollment
24
Registered
2026-06-23
Start date
2026-08-15
Completion date
2027-06-15
Last updated
2026-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior Maxilla Alveolar Bone Deficiency

Keywords

bone deficiency, khoury bone augmentation, anterior maxilla, vestibular shifted flap

Brief summary

two groups of patients both have alveolar bone deficiency in anterior maxilla, one group will be subjected to khoury bone augmentation with conventional flap the other with vestibular shifted flap

Detailed description

The procedure begins with preoperative preparation, including patient positioning in a semi supine position with appropriate head support, induction of local anesthesia, and meticulous surgical site sterilization. * Full thickness Vestibular flap and 2 horizontal releasing incision are made (Key Concept: The vestibular shifted flap provides additional flap length by translating vestibular mucosa coronally while preserving keratinized tissue and blood supply) in a group and conventional flap in the other group * Flap elevation: Full thickness flap in the Donor site * Using piezoelectric device, thin cortical bone blocks (1-1.5 mm thick) are harvested. * Blocks are carefully shaped into flat "plates." * The shell Graft placed, adapted and fixed with microscrews to restore desired horizontal dimension * The space between the host bone and the fixed cortical plates is filled with bone particles. * Tension free bilayered suturing

Interventions

The procedure begins with preoperative preparation, including patient positioning in a semi supine position with appropriate head support, induction of local anesthesia, and meticulous surgical site sterilization. * Full thickness conventional flap and 2 horizontal releasing incision are made * Flap elevation Full thickness flap in the Donor site * Using piezoelectric device, thin cortical bone blocks (1-1.5 mm thick) are harvested. * Blocks are carefully shaped into flat "plates." * The shell Graft placed, adapted and fixed with microscrews to restore desired horizontal dimension. * The space between the host bone and the fixed cortical plates is filled with bone particles. * Tension free bilayered suturing

PROCEDUREvestibular shifted flap for bone augmentation

The procedure begins with preoperative preparation, including patient positioning in a semi supine position with appropriate head support, induction of local anesthesia, and meticulous surgical site sterilization. * Full thickness Vestibular flap and 2 horizontal releasing incision are made (Key Concept: The vestibular shifted flap provides additional flap length by translating vestibular mucosa coronally while preserving keratinized tissue and blood supply) * Flap elevation: Full thickness flap in the Donor site * Using piezoelectric device, thin cortical bone blocks (1-1.5 mm thick) are harvested. * Blocks are carefully shaped into flat "plates." * The shell Graft placed, adapted and fixed with microscrews to restore desired horizontal dimension . • The space between the host bone and the fixed cortical plates is filled with bone particles. * Tension free bilayered suturing.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

This trial is considered a randomized single blind clinical trial due to: * The participants will be blinded to the technique that will be used during the surgical procedure. * The operator will not be blinded for both techniques during the surgical procedure as the two techniques are different. * The outcome assessor cannot be blinded.

Intervention model description

Parallel Assignment Randomized clinical trial A trial will be carried out in hospital of Oral and Maxilofacial surgery department- Faculty of Oral and Dental Medicine Cairo University. Equal randomization: participants with equal probabilities for intervention Positive controlled :Both groups receiving treatment Parallel group study: Each group of patients receives a single treatment simultaneously.

Eligibility

Sex/Gender
ALL
Age
21 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Adult patients with horizontal bone defects in anterior maxilla * Mixed dentition age (21-75) * Good periodontal health * Non smokers * Both genders males and females will be included

Exclusion criteria

* Uncontrolled systemic disease * General contraindications to surgery. * Patients participating in other studies, if the present protocol could not be properly followed.

Design outcomes

Primary

MeasureTime frameDescription
Horizontal Bone Gain Assessed in millimeters by Cone-Beam Computed Tomography (CBCT)6 monthsHorizontal bone gain will be evaluated using cone-beam computed tomography (CBCT). Alveolar ridge width will be measured in millimeters (mm) at standardized reference points before the augmentation procedure and at 6 months postoperatively. The outcome will be calculated as the change in ridge width (mm) from baseline to follow-up.

Secondary

MeasureTime frameDescription
Width of Keratinized Tissue Assessed by Periodontal Probe6 monthsThe width of keratinized tissue will be measured clinically using a calibrated periodontal probe and recorded in millimeters (mm) at baseline and 6 months postoperatively. The outcome will be calculated as the change in keratinized tissue width from baseline to follow-up.

Countries

Egypt

Contacts

CONTACTPiatrece Amgad Wadeea, BSc
piatrece.wadeea@dentistry.cu.edu.eg01288293090
CONTACTPiatrece Amgad Wadeaa, BSc
piatrece.wadeea@dentistry.cu.edu.eg01288293090
STUDY_DIRECTORSameh mekhemer, PHD

Mekhemer

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 24, 2026